Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management
暂无分享,去创建一个
J. Zucman‐Rossi | C. Balabaud | P. Bioulac-Sage | J. Blanc | A. S. Cunha | B. Bail | L. Mellottée | E. Lazaro
[1] J. Zucman‐Rossi,et al. Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC , 2006, Hepatology.
[2] J. Zucman‐Rossi,et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. , 2005, Gastroenterology.
[3] J. Zucman‐Rossi,et al. Bi-allelic inactivation of TCF1 in hepatic adenomas , 2002, Nature Genetics.
[4] H. Matsumoto,et al. A case of renal amyloidosis associated with hepatic adenoma: the pathogenetic role of tumor necrosis factor-alpha. , 1997, Nephron.
[5] J. Arenas,et al. Systemic AA amyloidosis induced by oral contraceptive-associated hepatocellular adenoma: a 13-year follow up. , 2008, Liver.
[6] Y. L. Le Treut,et al. [Inflammatory syndrome, anicteric cholestasis and hepatic adenoma]. , 1993, Journal de chirurgie.
[7] J. Chanard,et al. Remission of nephrotic syndrome related to AA amyloidosis after hepatic adenomectomy. , 1993, Nephron.
[8] L. Noel,et al. Systemic AA amyloidosis induced by liver cell adenoma. , 1990, Gut.
[9] C. Ingvar,et al. Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report. , 1986, Journal of hepatology.
[10] R. Bumsted,et al. Case Report and Literature Review , 1980 .